Greenbrook TMS Inc. (GBNH) Stock

About Greenbrook TMS Inc.

Greenbrook TMS Inc., and its associated entities, oversees and runs a broad array of outpatient mental healthcare centers throughout the United States. These specialized clinics primarily deliver transcranial magnetic stimulation (TMS) therapy, an FDA-approved, non-surgical treatment effective for major depressive disorder and various other mental health conditions. Additionally, they provide a suite of related psychiatric services. By the close of 2021, the company's operational reach extended to 149 TMS centers (94 wholly owned and 55 other facilities) dispersed across 17 U.S. states. These states include Virginia, Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.

Greenbrook TMS Inc. is headquartered in CA.

Greenbrook TMS Inc. (GBNH) stock trades at $0.12 with a market capitalization of $5.52M. The stock is valued at a price-to-earnings (P/E) ratio of -0.03, price-to-book of -0.10, price-to-sales of 0.08. Over the past 52 weeks the stock has ranged between $0.04 and $1.47, and currently trades 91.8% below its 52-week high.

On profitability, Greenbrook TMS Inc. generates a return on equity (ROE) of 310.71% — well above the market average, a sign of a high-quality business, return on capital employed of -46.51%, an operating margin of -42.60%, a net profit margin of -125.48%.

Official website: www.greenbrooktms.com